FORWARD-LOOKING
STATEMENTS
|
2
|
PROSPECTUS
SUMMARY
|
3
|
RISK
FACTORS
|
4
|
USE
OF PROCEEDS
|
8
|
SELLING
STOCKHOLDERS
|
8
|
PLAN
OF DISTRIBUTION
|
12
|
EXPERTS
|
14
|
WHERE
YOU CAN FIND MORE INFORMATION
|
14
|
INCORPORATION
OF CERTAIN DOCUMENTS BY REFERENCE
|
14
|
· |
Active
Investors II, Ltd. and Active Investors III, Ltd., which are
investors in our securities, are funds that are managed by Fundamental
Management Corporation. Messrs. O’Connor and Picow are two of our
directors and are also directors and shareholders of Fundamental
Management Corporation. Each of Messrs. O'Connor and Picow disclaim
any
beneficial ownership in the shares held by these
funds.
|
· |
Mr. Gathright
is one of our directors.
|
· |
Messrs.
Gathright, Beard, Messenbaugh, Shaw, Shore, Vinger and Williams are
seven
of our executive officers.
|
Ownership
of Shares Prior to Offering
|
|
Ownership
After Offering
|
|
||||||||||||||||
Name
|
|
Number
of Shares Beneficially Owned
|
|
Shares
of Common Stock Issuable Upon the Conversion of the Series A Preferred
Stock
|
|
Shares
of Common Stock Issuable Upon the Conversion of the Series B Preferred
Stock
|
|
Number
of Shares Being Offered for Sale in this Offering
|
|
Number
of Shares Beneficially Owned (1)
|
|
Percentage
|
|||||||
Active
Investors II Limited
|
1,324,380
(2
|
)
|
913,000
|
913,000
|
411,380
|
2.82
|
|||||||||||||
Active
Investors III Limited
|
1,328,742
(3
|
)
|
913,000
|
913,000
|
415,742
|
2.86
|
|||||||||||||
Robert
W. Beard
|
45,000
(4
|
)
|
10,000
|
10,000
|
35,000
|
*
|
|||||||||||||
Constance
Blass O’Neill Trust #3
|
157,904
(5
|
)
|
46,000
|
28,000
|
74,000
|
83,904
|
*
|
||||||||||||
Arnold
G. Bowles
|
199,737
(6
|
)
|
182,000
|
182,000
|
17,737
|
*
|
|||||||||||||
Frank
J. Campbell III
|
557,103
(7
|
)
|
274,000
|
274,000
|
283,103
|
1.94
|
|||||||||||||
DeWitt
Family Limited Partnership
|
182,000
(8
|
)
|
182,000
|
182,000
|
0
|
0
|
|||||||||||||
Roman
Fedorak
|
46,000
(9
|
)
|
46,000
|
46,000
|
0
|
0
|
|||||||||||||
Robert
Fisk
|
346,869
(10
|
)
|
319,000
|
319,000
|
27,869
|
*
|
|||||||||||||
Leon
Frenkel
|
384,767
(11
|
)
|
306,000
|
306,000
|
78,767
|
*
|
|||||||||||||
IRA
FBO Leonid Frenkel
Pershing
LLC, Custodian
|
396,753
(12
|
)
|
181,000
|
181,000
|
215,753
|
1.48
|
|||||||||||||
Richard
E. and Louise P. Gathright, JTWROS
|
575,250
(13
|
)
|
36,000
|
36,000
|
539,250
|
3.70
|
|||||||||||||
Alberto
Guadagnini
|
199,737
(14
|
)
|
182,000
|
182,000
|
17,737
|
*
|
|||||||||||||
Kevin
and Debra Hamilton, JTWROS
|
381,736
(15
|
)
|
364,000
|
364,000
|
17,736
|
*
|
|||||||||||||
1041
Partners, LP
|
422,000
(16
|
)
|
182,000
|
182,000
|
240,000
|
1.65
|
|||||||||||||
International
Investments, LLC
|
205,473
(17
|
)
|
170,000
|
170,000
|
35,473
|
*
|
|||||||||||||
Joshua
Tree Capital Partners, LP
|
1,200,741
(18
|
)
|
852,000
|
852,000
|
348,741
|
2.40
|
|||||||||||||
Sandra
Lockhart
|
45,000
(19
|
)
|
45,000
|
45,000
|
0
|
0
|
|||||||||||||
Isabelle
S. Malinowski
|
45,000
(20
|
)
|
45,000
|
45,000
|
0
|
0
|
|||||||||||||
Anthony
McDermott
|
200,000
(21
|
)
|
200,000
|
200,000
|
0
|
0
|
|||||||||||||
Sean
McDermott
|
105,158
(22
|
)
|
91,000
|
91,000
|
14,158
|
*
|
|||||||||||||
Laura
Patricia Messenbaugh
|
18,000
(23
|
)
|
9,000
|
9,000
|
9,000
|
*
|
|||||||||||||
Yury
& Eleonora Minkovsky,
Jt Ten.
|
45,000
(24
|
)
|
45,000
|
45,000
|
0
|
0
|
|||||||||||||
Alla
Pasternack
|
188,000
(25
|
)
|
182,000
|
182,000
|
6,000
|
*
|
|||||||||||||
Periscope
Partners L.P.
|
592,082
(26
|
)
|
164,000
|
164,000
|
428,082
|
2.94
|
|||||||||||||
Timothy
E. Shaw
|
41,000
(27
|
)
|
10,000
|
10,000
|
31,000
|
*
|
|||||||||||||
Michael
S. Shore
|
122,750
(28
|
)
|
36,000
|
36,000
|
86,750
|
*
|
|||||||||||||
Triage
Capital Management, L.P.
|
835,390
(29
|
)
|
437,000
|
437,000
|
398,390
|
2.74
|
|||||||||||||
Paul
C. Vinger
|
114,500
(30
|
)
|
36,000
|
36,000
|
78,500
|
*
|
|||||||||||||
Gary
G. Williams III and Diane F. Williams, JTWROS
|
105,500
(31
|
)
|
18,000
|
18,000
|
87,500
|
*
|
|||||||||||||
Mark
D. Wittman
|
147,347
(32
|
)
|
40,000
|
28,000
|
68,000
|
79,347
|
*
|
||||||||||||
10,558,919
|
4,587,000
|
1,985,000
|
6,572,000
|
3,986,919
|
(1)
|
Assumes
that (i) all of the shares of Preferred Stock are converted into
common
stock, (ii) all of the shares of common stock currently beneficially
owned
by the Selling Stockholders and registered hereunder are sold, and
(iii)
the Selling Stockholder acquires no additional shares of common stock
before the completion of this
offering.
|
(2)
|
Includes
913,000 shares of common stock issuable upon conversion of the Series
A
Preferred Stock.
|
(3)
|
Includes
913,000 shares of common stock issuable upon conversion of the Series
A
Preferred Stock.
|
(4)
|
Includes
10,000 shares of common stock issuable upon conversion of the Series
A
Preferred Stock and 35,000 shares of common stock issuable upon exercise
of certain stock options.
|
(5)
|
Includes
46,000 shares of common stock issuable upon conversion of the Series
A
Preferred Stock, 28,000 shares of common stock issuable upon conversion
of
the Series B Preferred Stock, and 83,904 shares of common stock issuable
upon conversion of certain promissory
notes.
|
(6)
|
Includes
182,000 shares of common stock issuable upon conversion of the Series
A
Preferred Stock and 845 shares of common stock issuable upon exercise
of
certain warrants.
|
(7)
|
Includes
274,000 shares of common stock issuable upon conversion of the Series
A
Preferred Stock and 17,668 shares of common stock issuable upon the
exercise of certain warrants. This also includes 200,000 shares of
common
stock held in the Selling Stockholder’s IRA account and 30,000 shares of
common stock issuable upon the exercise of certain warrants, also
held in
the Selling Stockholders IRA
account.
|
(8)
|
Includes
182,000 shares of common stock issuable upon conversion of the Series
A
Preferred Stock.
|
(9)
|
Includes
46,000 shares of common stock issuable upon conversion of the Series
A
Preferred Stock.
|
(10)
|
Includes
319,000 shares of common stock issuable upon conversion of the Series
A
Preferred Stock and 982 shares of common stock issuable upon exercise
of
certain warrants.
|
(11)
|
Includes
306,000 shares of common stock issuable upon conversion of the Series
B
Preferred Stock and 78,767 shares of common stock issuable upon conversion
of certain promissory notes.
|
(12)
|
Includes
181,000 shares of common stock issuable upon conversion of the Series
A
Preferred Stock and 215,753 shares of common stock issuable upon
conversion of certain promissory
notes.
|
(13)
|
Includes
36,000 shares of common stock issuable upon conversion of the Series
A
Preferred Stock and 531,000 shares of common stock issuable upon
exercise
of certain stock options.
|
(14)
|
Includes
182,000 shares of common stock issuable upon conversion of the Series
A
Preferred Stock and 845 shares of common stock issuable upon exercise
of
certain warrants.
|
(15)
|
Includes
364,000 shares of common stock issuable upon conversion of the Series
A
Preferred Stock and 7,802 shares of common stock issuable upon exercise
of
certain warrants
|
(16)
|
Includes
182,000 shares of common stock issuable upon conversion of the Series
A
Preferred Stock and 40,000 shares of common stock issuable upon exercise
of certain warrants. Selling Stockholder has identified Kevin Hamilton
as
its general partner as a natural person with sole voting and dispositive
power over the shares.
|
(17)
|
Includes
170,000 shares of common stock issuable upon conversion of the Series
B
Preferred Stock and 1,689 shares of common stock issuable upon exercise
of
certain warrants.
|
(18)
|
Includes
852,000 shares of common stock issuable upon conversion of the Series
B
Preferred Stock, 91,892 shares of common stock issuable upon exercise
of
certain warrants, and 256,849 shares of common stock issuable upon
conversion of certain promissory
notes.
|
(19)
|
Includes
45,000 shares of common stock issuable upon conversion of the Series
A
Preferred Stock.
|
(20)
|
Includes
45,000 shares of common stock issuable upon conversion of the Series
A
Preferred Stock.
|
(21)
|
Includes
200,000 shares of common stock issuable upon conversion of the Series
A
Preferred Stock.
|
(22)
|
Includes
91,000 shares of common stock issuable upon conversion of the Series
A
Preferred Stock and 6,019 shares of common stock issuable upon exercise
of
certain warrants.
|
(23)
|
Includes
9,000 shares of common stock issuable upon conversion of the Series
A
Preferred Stock and 9,000 shares of common stock issuable upon exercise
of
certain stock options.
|
(24)
|
Includes
45,000 shares of common stock issuable upon conversion of the Series
A
Preferred Stock.
|
(25)
|
Includes
182,000 shares of common stock issuable upon conversion of the Series
A
Preferred Stock and 6,000 shares of common stock issuable upon exercise
of
certain warrants.
|
(26)
|
Includes
164,000 shares of common stock issuable upon conversion of the Series
B
Preferred Stock and 428,082 shares of common stock issuable upon
conversion of certain promissory
notes.
|
(27)
|
Includes
10,000 shares of common stock issuable upon conversion of the Series
A
Preferred Stock and 31,000 shares of common stock issuable upon exercise
of certain stock options.
|
(28)
|
Includes
36,000 shares of common stock issuable upon conversion of the Series
A
Preferred Stock and 85,000 shares of common stock issuable upon exercise
of certain stock options.
|
(29)
|
Includes
437,000 shares of common stock issuable upon conversion of the Series
B
Preferred Stock, 84,032 shares of common stock issuable upon exercise
of
certain warrants, and 314,358 shares of common stock issuable upon
conversion of certain promissory notes. The Selling Stockholder has
identified Leon Frenkel as the Managing Member of Triage Capital
LF Group
LLC which acts as the general partner to a general partner of Triage
Capital Management, LP, as a natural person with sole voting and
dispositive power over the shares.
|
(30)
|
Includes
36,000 shares of common stock issuable upon conversion of the Series
A
Preferred Stock and 76,000 shares of common stock issuable upon exercise
of certain stock options.
|
(31)
|
Includes
18,000 shares of common stock issuable upon conversion of the Series
A
Preferred Stock and 85,000 shares of common stock issuable upon exercise
of certain stock options.
|
(32) |
Includes
40,000 shares of common stock issuable upon conversion of the Series
A
Preferred Stock, 28,000 shares of common stock issuable upon conversion
of
the Series B Preferred Stock, 21,600 shares of common stock issuable
upon
exercise of certain warrants, 34,247 shares of common stock issuable
upon
conversion of certain promissory
notes.
|
· |
on
the Nasdaq Capital Market,
|
· |
in
the over-the-counter market,
|
· |
in
privately negotiated transactions,
|
· |
for
settlement of short sales, or through long sales, options or transactions
involving cross or block trades,
|
· |
by
pledges to secure debts and other obligations,
or
|
· |
in
a combination of any of these
transactions.
|
· |
our
Annual Report on Form 10-K for the year ended June 30, 2007;
|
· |
our
Quarterly Reports on Form 10-Q for the quarters ended
September 30, 2007, December 31, 2007 and March 31,
2008;
|
· |
our
Definitive Proxy Statement on Schedule 14A, filed on October 26,
2007;
|
· |
our
Current Reports on Form 8-K filed with the SEC on August 14,
2007; October 12, 2007; November 2, 2007, November 23,
2007, December 31, 2007, February 22, 2008, March 6, 2008,
March 14, 2008 and April 9, 2008;
and
|
· |
the
description of our common stock contained in Amendment No. 2 to our
Registration Statement on Form 8-A/A (SEC File No. 000-21825) filed
with
the SEC on June 5, 2007.
|